Sunesis Pharmaceuticals, Inc. (SNSS)

0.90
0.01 1.10
NASDAQ
Prev Close 0.89
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.44 / 1.29
Exchange NASDAQ
Shares Outstanding 87.01B
Market Cap 68.74M
Div & Yield N.A. (N.A)

Latest News

Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 11:00 AM Eastern Time

Sunesis Announces Study Examining The Value Of Complete Remission Prior To HCT In Patients With AML Presented At 2016 ASCO Annual Meeting

Sunesis Announces Study Examining The Value Of Complete Remission Prior To HCT In Patients With AML Presented At 2016 ASCO Annual Meeting

Study Funded Jointly by Sunesis and the Center for International Blood and Marrow Transplant Research

Insider Trading Alert - PODD, POWI And SNSS Traded By Insiders

Insider Trading Alert - PODD, POWI And SNSS Traded By Insiders

Stocks with insider trader activity include PODD, POWI and SNSS

Sunesis Pharmaceuticals Reports First Quarter 2016 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports First Quarter 2016 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 11:00 AM Eastern Time

Sunesis Pharmaceuticals Announces First Subject Dosed In Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK-inhibitor SNS-062

Sunesis Pharmaceuticals Announces First Subject Dosed In Phase 1A Healthy Volunteer Study Evaluating Oral Non-Covalent BTK-inhibitor SNS-062

Study Start Marks Sunesis' Second Kinase Inhibitor Program to Enter the Clinic

Sunesis Pharmaceuticals Reports Fourth Quarter And Full-Year 2015 Financial Results And Recent Highlights

Sunesis Pharmaceuticals Reports Fourth Quarter And Full-Year 2015 Financial Results And Recent Highlights

Sunesis to Host Conference Call Today at 11:00 AM Eastern Time